ADMA Biologics (ADMA, $9.21) was one of top quarterly gainers, jumping +7 to $9.21 per share. A.I.dvisor analyzed 903 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down. A.I.dvisor found 380 similar cases when ADMA's price went up within three months. In out of those 380 cases, ADMA's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for ADMA are